Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism
1 other identifier
interventional
55
1 country
1
Brief Summary
With increasing demands of patients concerning refractive outcome after cataract surgery, toric intraocular lenses (IOLs) that correct corneal astigmatism have been introduced more widely to cataract surgery. Originally toric IOLs were used mainly for patients with high degrees of astigmatism, especially after corneal surgical procedures such as penetrating keratoplasty. Since a couple of years, toric IOLs are available from numerous manufacturers to correct lower amounts of astigmatism which are much more prevalent with about 30% having a corneal astigmatism of 0.75D or more in the cataract population. This should result in less spectacle dependence of patients due to the astigmatic correction. The alternative method to reduce corneal astigmatism as part of cataract surgery is to make incisions on the steeper axis of the cornea such as limbal relaxing incisions or an additional clear corneal incision opposite (OCCI) to the main cataract opening. These techniques are in use since more than 2 decades and are widely used in clinical routine. As with toric IOLs, precise alignment of the cuts with the axis of astigmatism is essential. The disadvantage of the incisional techniques is the variability of the effect between patients since it depends on factors such as the extent of scaring of the cuts after surgery as well as corneal thickness. The main advantage is the simplicity of the technique and the lower cost. Aim of this study is to compare toric IOL implantation and opposite clear corneal incision during cataract surgery to correct corneal astigmatism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Sep 2010
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 6, 2013
CompletedFirst Posted
Study publicly available on registry
January 8, 2013
CompletedJanuary 10, 2013
January 1, 2013
1.9 years
January 6, 2013
January 8, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative residual astigmatism
9 months post-operatively
Secondary Outcomes (1)
uncorrected distance visual acuity (UDVA)
9 months post-operatively
Other Outcomes (1)
postoperative IOL rotation
3 months and 9 months post-operatively
Study Arms (2)
toric IOL
ACTIVE COMPARATORaspherical, toric acrylic IOL (Lentis L-312T, Oculentis, Germany)
IOL combined with opposite clear corneal incision (OCCI)
ACTIVE COMPARATORaspherical, acrylic IOL with OCCI
Interventions
aspherical, acrylic IOL with opposite clear corneal incision during cataract surgery
Eligibility Criteria
You may qualify if:
- Cataract
- Age 21 and older
- Regular corneal astigmatism 1.0 up to 2.5 D
- written informed consent prior to surgery
You may not qualify if:
- Relevant other ophthalmic diseases such as: pseudoexfoliation, glaucoma, traumatic cataract corneal scars, and other co-morbidity that could affect capsule bag stability ( e.g. Marfan syndrome)
- Irregular corneal astigmatism on corneal topography
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital
Vienna, 1140, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, MBA
Study Record Dates
First Submitted
January 6, 2013
First Posted
January 8, 2013
Study Start
September 1, 2010
Primary Completion
August 1, 2012
Study Completion
December 1, 2012
Last Updated
January 10, 2013
Record last verified: 2013-01